These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8597089)

  • 1. Novel enzymatic and immunological responses to oligonucleotides.
    Agrawal S; Rustagi PK; Shaw DR
    Toxicol Lett; 1995 Dec; 82-83():431-4. PubMed ID: 8597089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of synthetic oligonucleotides on human complement and coagulation.
    Shaw DR; Rustagi PK; Kandimalla ER; Manning AN; Jiang Z; Agrawal S
    Biochem Pharmacol; 1997 Apr; 53(8):1123-32. PubMed ID: 9175717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of coagulation by a phosphorothioate oligonucleotide.
    Henry SP; Novotny W; Leeds J; Auletta C; Kornbrust DJ
    Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):503-10. PubMed ID: 9361909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
    Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
    Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
    J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity.
    Tang JY; Temsamani J; Agrawal S
    Nucleic Acids Res; 1993 Jun; 21(11):2729-35. PubMed ID: 8392706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey.
    Galbraith WM; Hobson WC; Giclas PC; Schechter PJ; Agrawal S
    Antisense Res Dev; 1994; 4(3):201-6. PubMed ID: 7849490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
    Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study.
    Tonkinson JL; Guvakova M; Khaled Z; Lee J; Yakubov L; Marshall WS; Caruthers MH; Stein CA
    Antisense Res Dev; 1994; 4(4):269-78. PubMed ID: 7537561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
    Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
    Stein CA; Cheng YC
    Science; 1993 Aug; 261(5124):1004-12. PubMed ID: 8351515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Tsuchiya S
    Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):319-27. PubMed ID: 9743469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity.
    Chen W; Langer RM; Janczewska S; Furian L; Geary R; Qu X; Wang M; Verani R; Condon T; Stecker K; Bennett CF; Stepkowski SM
    Transplantation; 2005 Feb; 79(4):401-8. PubMed ID: 15729165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.
    Storey A; Oates D; Banks L; Crawford L; Crook T
    Nucleic Acids Res; 1991 Aug; 19(15):4109-14. PubMed ID: 1651476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides.
    Arima H; Sakamoto T; Aramaki Y; Ishidate K; Tsuchiya S
    J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
    Ghosh MK; Ghosh K; Cohen JS
    Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys.
    Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ
    Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.
    Henry SP; Giclas PC; Leeds J; Pangburn M; Auletta C; Levin AA; Kornbrust DJ
    J Pharmacol Exp Ther; 1997 May; 281(2):810-6. PubMed ID: 9152389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.